Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
editorial
. 1991 Mar;63(3):343–345. doi: 10.1038/bjc.1991.81

The applications of positron emission tomography to oncology.

R J Ott
PMCID: PMC1971857  PMID: 2003973

Full text

PDF
343

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alavi J. B., Alavi A., Chawluk J., Kushner M., Powe J., Hickey W., Reivich M. Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer. 1988 Sep 15;62(6):1074–1078. doi: 10.1002/1097-0142(19880915)62:6<1074::aid-cncr2820620609>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  2. Bergström M., Muhr C., Lundberg P. O., Bergström K., Gee A. D., Fasth K. J., Långström B. Rapid decrease in amino acid metabolism in prolactin-secreting pituitary adenomas after bromocriptine treatment: a PET study. J Comput Assist Tomogr. 1987 Sep-Oct;11(5):815–819. doi: 10.1097/00004728-198709000-00014. [DOI] [PubMed] [Google Scholar]
  3. Brooks D. J., Beaney R. P., Lammertsma A. A., Herold S., Turton D. R., Luthra S. K., Frackowiak R. S., Thomas D. G., Marshall J., Jones T. Glucose transport across the blood-brain barrier in normal human subjects and patients with cerebral tumours studied using [11C]3-O-methyl-D-glucose and positron emission tomography. J Cereb Blood Flow Metab. 1986 Apr;6(2):230–239. doi: 10.1038/jcbfm.1986.36. [DOI] [PubMed] [Google Scholar]
  4. Flower M. A., Schlesinger T., Hinton P. J., Adam I., Masoomi A. M., Elbelli M. A., Ott R. J., McCready V. R., Harmer C. L. Radiation dose assessment in radioiodine therapy. 2. Practical implementation using quantitative scanning and PET, with initial results on thyroid carcinoma. Radiother Oncol. 1989 Aug;15(4):345–357. doi: 10.1016/0167-8140(89)90081-9. [DOI] [PubMed] [Google Scholar]
  5. Muhr C., Bergström M., Lundberg P. O., Bergström K., Hartvig P., Lundqvist H., Antoni G., Långström B. Dopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperone. J Comput Assist Tomogr. 1986 Mar-Apr;10(2):175–180. doi: 10.1097/00004728-198603000-00001. [DOI] [PubMed] [Google Scholar]
  6. Ott R. J., Batty V., Webb B. S., Flower M. A., Leach M. O., Clack R., Marsden P. K., McCready V. R., Bateman J. E., Sharma H. Measurement of radiation dose to the thyroid using positron emission tomography. Br J Radiol. 1987 Mar;60(711):245–251. doi: 10.1259/0007-1285-60-711-245. [DOI] [PubMed] [Google Scholar]
  7. Patronas N. J., Di Chiro G., Brooks R. A., DeLaPaz R. L., Kornblith P. L., Smith B. H., Rizzoli H. V., Kessler R. M., Manning R. G., Channing M. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain. Radiology. 1982 Sep;144(4):885–889. doi: 10.1148/radiology.144.4.6981123. [DOI] [PubMed] [Google Scholar]
  8. Valk P. E., Budinger T. F., Levin V. A., Silver P., Gutin P. H., Doyle W. K. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg. 1988 Dec;69(6):830–838. doi: 10.3171/jns.1988.69.6.0830. [DOI] [PubMed] [Google Scholar]
  9. Wilson C. B. Metabolic imaging of human brain tumors. Semin Neurol. 1989 Dec;9(4):388–393. doi: 10.1055/s-2008-1041349. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES